Vaxart

VXRT

VXRT Vaxart NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    VXRT Chart
    See on advanced chart >

    About

    Vaxart, Inc. is a clinical-stage company focused on developing oral recombinant protein vaccines based on its proprietary oral vaccine platform and direct-acting antivirals to treat infections that have limited therapeutic options. Vaxart's oral vaccines are...
    • Highlight
      A company that developing anti-infective drugs primarily for respiratory diseases
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      12/11/1981
    • Established Date
      Invalid Date
    • Full-time Employees
      109
    • Address
      170 Harbor Way Suite 300 South San Francisco California 94080
    • Tel
      1-650-5503500
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-04-17 07:41:39